Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal




Singer, CF; Jahn, SW; Rudas, M; Bago-Horvath, Z; Fitzal, F; Abete, L; Moinfar, F; Gnant, M; Filipits, M, , Austrian, Breast, and, Colorectal, Cancer, Study, Group, (ABCSG) Independent validation of stromal uPA in ABCSG-08: Level 1b evidence for the prognostic value of uPA immunohistochemistry.
Breast. 2022; 64:127-133 Doi: 10.1016/j.breast.2022.05.003 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG



Barth, DA; Riedl, JM; Posch, F; Smolle, MA; Kasparek, AK; Niedrist, T; Szkandera, J; Stöger, H; Pichler, M; Stotz, M; Gerger, A Critical evaluation of platelet size as a prognostic biomarker in colorectal cancer across multiple treatment settings: a retrospective cohort study.
Clin Transl Oncol. 2019; 21(8):1034-1043 Doi: 10.1007/s12094-019-02037-7 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG



Czink, E; Heining, C; Weber, TF; Lasitschka, F; Schemmer, P; Schirmacher, P; Weiss, KH; Glimm, H; Brors, B; Weichert, W; Jäger, D; Fröhling, S; Springfeld, C [Durable remission under dual HER2 blockade with Trastuzumab and Pertuzumab in a patient with metastatic gallbladder cancer].
Z Gastroenterol. 2016; 54(5):426-430 Doi: 10.1055/s-0042-103498
Web of Science PubMed FullText FullText_MUG


Goldinger, SM; Gobbi Bischof, S; Fink-Puches, R; Klemke, CD; Dréno, B; Bagot, M; Dummer, R Efficacy and Safety of APO866 in Patients With Refractory or Relapsed Cutaneous T-Cell Lymphoma: A Phase 2 Clinical Trial.
JAMA Dermatol. 2016; 152(7):837-839 Doi: 10.1001/jamadermatol.2016.0401 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG


Prochazka, KT; Melchardt, T; Posch, F; Schlick, K; Deutsch, A; Beham-Schmid, C; Weiss, L; Gary, T; Neureiter, D; Klieser, E; Greil, R; Neumeister, P; Egle, A; Pichler, M NCCN-IPI score-independent prognostic potential of pretreatment uric acid levels for clinical outcome of diffuse large B-cell lymphoma patients.
Br J Cancer. 2016; 115(10):1264-1272 Doi: 10.1038/bjc.2016.325 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG


Sehouli, J; Chekerov, R; Reinthaller, A; Richter, R; Gonzalez-Martin, A; Harter, P; Woopen, H; Petru, E; Hanker, LC; Keil, E; Wimberger, P; Klare, P; Kurzeder, C; Hilpert, F; Belau, AK; Zeimet, A; Bover-Barcelo, I; Canzler, U; Mahner, S; Meier, W Topotecan plus carboplatin versus standard therapy with paclitaxel plus carboplatin (PC) or gemcitabine plus carboplatin (GC) or pegylated liposomal doxorubicin plus carboplatin (PLDC): a randomized phase III trial of the NOGGO-AGO-Study Group-AGO Austria and GEICO-ENGOT-GCIG intergroup study (HECTOR).
Ann Oncol. 2016; 27(12):2236-2241 Doi: 10.1093/annonc/mdw418 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG



Fastner, G; Reitsamer, R; Ziegler, I; Zehentmayr, F; Fussl, C; Kopp, P; Peintinger, F; Greil, R; Fischer, T; Deutschmann, H; Sedlmayer, F IOERT as anticipated tumor bed boost during breast-conserving surgery after neoadjuvant chemotherapy in locally advanced breast cancer--results of a case series after 5-year follow-up.
Int J Cancer. 2015; 136(5): 1193-1201. Doi: 10.1002/ijc.29064 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG


Volgger, B; Zeimet, AG; Reinthaller, A; Petru, E; Schauer, C; Klein, M; Sevelda-Schwarzgruber, U; Bogner, G; Wolfram, G; Marth, C Carboplatin and nonpegylated liposomal doxorubicin in primary advanced or recurrent endometrial cancer: a phase 2 trial conducted by AGO Austria.
Int J Gynecol Cancer. 2015; 25(2):257-262 Doi: 10.1097/IGC.0000000000000352 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG



Absenger, G; Benhaim, L; Szkandera, J; Zhang, W; Yang, D; Labonte, MJ; Pichler, M; Stotz, M; Samonigg, H; Renner, W; Gerger, A; Lenz, HJ The cyclin D1 (CCND1) rs9344 G>A polymorphism predicts clinical outcome in colon cancer patients treated with adjuvant 5-FU-based chemotherapy.
Pharmacogenomics J. 2014; 14(2):130-134 Doi: 10.1038/tpj.2013.15
Web of Science PubMed FullText FullText_MUG Google Scholar


Hutterer, M; Nowosielski, M; Haybaeck, J; Embacher, S; Stockhammer, F; Gotwald, T; Holzner, B; Capper, D; Preusser, M; Marosi, C; Oberndorfer, S; Moik, M; Buchroithner, J; Seiz, M; Tuettenberg, J; Herrlinger, U; Wick, A; Vajkoczy, P; Stockhammer, G A single-arm phase II Austrian/German multicenter trial on continuous daily sunitinib in primary glioblastoma at first recurrence (SURGE 01-07).
Neuro Oncol. 2014; 16(1):92-102 Doi: 10.1093/neuonc/not161 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG



Batchelor, TT; Mulholland, P; Neyns, B; Nabors, LB; Campone, M; Wick, A; Mason, W; Mikkelsen, T; Phuphanich, S; Ashby, LS; Degroot, J; Gattamaneni, R; Cher, L; Rosenthal, M; Payer, F; Jürgensmeier, JM; Jain, RK; Sorensen, AG; Xu, J; Liu, Q; van den Bent, M Phase III randomized trial comparing the efficacy of cediranib as monotherapy, and in combination with lomustine, versus lomustine alone in patients with recurrent glioblastoma.
J Clin Oncol. 2013; 31(26):3212-3218 Doi: 10.1200/JCO.2012.47.2464 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG


Pfeiffenberger, J; Koschny, R; Hoffmann, K; Mehrabi, A; Schmitz, A; Radeleff, B; Stremmel, W; Schemmer, P; Ganten, TM Sorafenib treatment is save and may affect survival of recurrent hepatocellular carcinoma after liver transplantation.
Langenbecks Arch Surg. 2013; 398(8):1123-1128 Doi: 10.1007/s00423-013-1114-1
Web of Science PubMed FullText FullText_MUG



Kurtz, JE; Kaminsky, MC; Floquet, A; Veillard, AS; Kimmig, R; Dorum, A; Elit, L; Buck, M; Petru, E; Reed, N; Scambia, G; Varsellona, N; Brown, C; Pujade-Lauraine, E; on behalf of Gynecologic Cancer Intergroup Ovarian cancer in elderly patients: carboplatin and pegylated liposomal doxorubicin versus carboplatin and paclitaxel in late relapse: a Gynecologic Cancer Intergroup (GCIG) CALYPSO sub-study.
ANN ONCOL. 2011; 22(11): 2417-2423. Doi: 10.1093/annonc/mdr001 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar


Youssef, RF; Shariat, SF; Lotan, Y; Wood, CG; Sagalowsky, AI; Zigeuner, R; Kikuchi, E; Weizer, A; Raman, JD; Remzi, M; Kabbani, W; Langner, C; Guo, CC; Roscigno, M; Montorsi, F; Bolenz, C; Kassouf, W; Margulis, V Upper urinary tract urothelial carcinoma with loco-regional nodal metastases: insights from the Upper Tract Urothelial Carcinoma Collaboration.
BJU Int. 2011; 108(8): 1286-1291. Doi: 10.1111/j.1464-410X.2011.10075.x [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG



Petru, E; Reinthaller, A; Angleitner-Boubenizek, L; Schauer, C; Zeimet, A; Dirschlmayer, W; Medl, M; Stummvoll, W; Sevelda, P; Marth, C Clinical consequences of the Calypso trial showing superiority of PEG-liposomal doxorubicin and carboplatin over paclitaxel and carboplatin in recurrent ovarian cancer: results of an Austrian gynecologic oncologists' expert meeting.
WIEN KLIN WOCHENSCHR. 2010; 122(21-22): 649-652. Doi: 10.1007/s00508-010-1483-1
Web of Science PubMed FullText FullText_MUG



Kohlfurst, S; Markitz, M; Raunik, W; Eckel, HE; Kresnik, E; Hausegger, K; Salzwimmer, M; Gaggl, A; Chiari, F; Lind, P Positron-emission tomography (PET) and PET/CT in head and neck cancer - recommendations of an interdisciplinary consensus conference
LARYNGO RHINO OTOL. 2009; 88(2): 84-90. Doi: 10.1055/s-0028-1119439
Web of Science PubMed FullText FullText_MUG


Leithner, K; Stacher, E; Wurm, R; Ploner, F; Quehenberger, F; Wohlkoenig, C; Bálint, Z; Polachova, J; Olschewski, A; Samonigg, H; Popper, HH; Olschewski, H Nuclear and cytoplasmic death receptor 5 as prognostic factors in patients with non-small cell lung cancer treated with chemotherapy.
Lung Cancer. 2009; 65(1):98-104 Doi: 10.1016/j.lungcan.2008.10.015
Web of Science PubMed FullText FullText_MUG Google Scholar



Benesch, M; Windelberg, M; Sauseng, W; Witt, V; Fleischhack, G; Lackner, H; Gadner, H; Bode, U; Urban, C Compassionate use of bevacizumab (Avastin) in children and young adults with refractory or recurrent solid tumors.
Ann Oncol. 2008; 19(4): 807-813. Doi: 10.1093/annonc/mdm510 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG


Huber, J; Sovinz, P; Freidl, T; Jahnel, J; Lackner, H; Höllwarth, M; Otte, JB; Urban, C Long term survival in two children with rhabdomyosarcoma of the biliary tract.
Klin Padiatr. 2008; 220(6): 378-379. Doi: 10.1055/s-0028-1083792 (- Case Report)
Web of Science PubMed FullText FullText_MUG


Kropf, N; McCarthy, CM; Disa, JJ Breast cancer local recurrence after breast reconstruction.
Handchir Mikrochir Plast Chir. 2008; 40(4): 219-224. Doi: 10.1055/s-2008-1038599
Web of Science PubMed FullText FullText_MUG



Pötter, R; Gnant, M; Kwasny, W; Tausch, C; Handl-Zeller, L; Pakisch, B; Taucher, S; Hammer, J; Luschin-Ebengreuth, G; Schmid, M; Sedlmayer, F; Stierer, M; Reiner, G; Kapp, K; Hofbauer, F; Rottenfusser, A; Pöstlberger, S; Haider, K; Draxler, W; Jakesz, R; Austrian Breast and Colorectal Cancer Study Group Lumpectomy plus tamoxifen or anastrozole with or without whole breast irradiation in women with favorable early breast cancer.
INT J RADIAT ONCOL BIOL PHYS. 2007; 68(2): 334-340. Doi: 10.1016/j.ijrobp.2006.12.045
Web of Science PubMed FullText FullText_MUG


Rhodes, LE; de Rie, MA; Leifsdottir, R; Yu, RC; Bachmann, I; Goulden, V; Wong, GA; Richard, MA; Anstey, A; Wolf, P Five-year follow-up of a randomized, prospective trial of topical methyl aminolevulinate photodynamic therapy vs surgery for nodular basal cell carcinoma.
ARCH DERMATOL. 2007; 143(9): 1131-1136. Doi: 10.1001/archderm.143.9.1131 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar



Hassler, M; Micksche, M; Stockhammer, G; Pichler, J; Payer, F; Abuja, B; Deinsberger, R; Marosi, C Temozolomide for recurrent or progressive high-grade malignant glioma: results of an Austrian multicenter observational study.
Wien Klin Wochenschr. 2006; 118(7-8):230-238 Doi: 10.1007/s00508-006-0576-3
Web of Science PubMed FullText FullText_MUG


Petru, E; Angleitner-Boubenizek, L; Reinthaller, A; Deibl, M; Zeimet, AG; Volgger, B; Stempfl, A; Marth, C Combined PEG liposomal doxorubicin and gemcitabine are active and have acceptable toxicity in patients with platinum-refractory and -resistant ovarian cancer after previous platinum-taxane therapy: a phase II Austrian AGO study.
Gynecol Oncol. 2006; 102(2):226-229 Doi: 10.1016/j.ygyno.2005.12.017
Web of Science PubMed FullText FullText_MUG Google Scholar



Nogales, FF; Buriticá, C; Regauer, S; González, T Mucinous carcinoid as an unusual manifestation of endodermal differentiation in ovarian yolk sac tumors.
Am J Surg Pathol. 2005; 29(9):1247-1251 Doi: 10.1097/01.pas.0000161533.39478.a7 (- Case Report)
Web of Science PubMed FullText FullText_MUG



Wolf, IH; Smolle, J; Binder, B; Cerroni, L; Richtig, E; Kerl, H Topical imiquimod in the treatment of metastatic melanoma to skin.
Arch Dermatol. 2003; 139(3):273-276 Doi: 10.1001/archderm.139.3.273 (- Case Report) [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar



Kortmann, RD; Kühl, J; Timmermann, B; Calaminus, G; Dieckmann, K; Wurm, R; Sörensen, N; Urban, C; Göbel, U; Bamberg, M Current and future strategies in interdisciplinary treatment of medulloblastomas, supratentorial PNET (primitive neuroectodermal tumors) and intracranial germ cell tumors in childhood
Strahlenther Onkol. 2001; 177(9): 447-461. Doi: 10.1007/PL00002426
Web of Science PubMed FullText FullText_MUG Google Scholar



Kortmann, RD; Kühl, J; Timmermann, B; Mittler, U; Urban, C; Budach, V; Richter, E; Willich, N; Flentje, M; Berthold, F; Slavc, I; Wolff, J; Meisner, C; Wiestler, O; Sörensen, N; Warmuth-Metz, M; Bamberg, M Postoperative neoadjuvant chemotherapy before radiotherapy as compared to immediate radiotherapy followed by maintenance chemotherapy in the treatment of medulloblastoma in childhood: results of the German prospective randomized trial HIT '91.
INT J RADIAT ONCOL BIOL PHYS. 2000; 46(2): 269-279. Doi: 10.1016/S0360-3016(99)00369-7
Web of Science PubMed FullText FullText_MUG Google Scholar


Leithner, A; Schnack, B; Katterschafka, T; Wiltschke, C; Amann, G; Windhager, R; Kotz, R; Zielinski, CC Treatment of extra-abdominal desmoid tumors with interferon-alpha with or without tretinoin.
J Surg Oncol. 2000; 73(1):21-25 Doi: 10.1002%2F%28SICI%291096-9098%28200001%2973%3A1%3C21%3A%3AAID-JSO6%3E3.0.CO%3B2-G
Web of Science PubMed FullText FullText_MUG



Thödtmann, F; Theiss, F; Kemmerich, M; Heinrich, B; Laubenbacher, C; Quasthoff, S; Kau, R; Herzog, M; Diergarten, K; Hanauske, AR Clinical phase II evaluation of paclitaxel in combination with cisplatin in metastatic or recurrent squamous cell carcinoma of the head and neck.
Ann Oncol. 1998; 9(3):335-337 Doi: 10.1023/A:1008298915121 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG



Hanauske, AR; Schilling, T; Heinrich, B; Kau, R; Herzog, M; Quasthoff, S; Bochtler, H; Diergarten, K; Rastetter, J Clinical phase I study of paclitaxel followed by cisplatin in advanced head and neck squamous cell carcinoma.
Semin Oncol. 1995; 22(6 Suppl 14):35-39
Web of Science PubMed



Göbel, U; Calaminus, G; Teske, C; Bamberg, M; Bökkerink, JP; Haas, RJ; Holschneider, AM; Janka-Schaub, G; Jürgens, H; Mittler, U BEP/VIP in children and adolescents with malignant non-testicular germ cell tumors. A comparison of the results of treatment of therapy studies MAKEI 83/86 and 89P/89
KLIN PADIAT. 1993; 205(4): 231-240. Doi: 10.1055/s-2007-1025232
Web of Science PubMed FullText FullText_MUG



Gruemayer, ER; Gadner, H; Mutz, I; Urban, C; Ausserer, B; Grienberger, H; Juergenssen, O; Koeller, U; Mueller, G; Panzer, S Childhood acute lymphoblastic leukemia: results of the Austrian Cooperative Study Group with the ALL A 84 protocol.
Med Pediatr Oncol. 1990; 18(1):6-14 Doi: 10.1002/mpo.2950180103
Web of Science PubMed FullText FullText_MUG Google Scholar



Lahousen, M; Haas, H; Pickel, H Adjuvant chemotherapy in radical surgery of cervix cancer
Gynakol Rundsch. 1989; 29 Suppl 2(4): 372-374. Doi: 10.1159/000271120
PubMed FullText FullText_MUG


Scherlacher, A; Jakse, R; Lehnert, M; Haas, J Factors modifying remission in cytostatic chemotherapy of squamous cell carcinoma recurrence in the area of the head and neck
LARYNGO RHINO OTOL. 1989; 68(8): 425-432. Doi: 10.1055/s-2007-998369
Web of Science PubMed FullText FullText_MUG



Steindorfer, P; Jakse, R; Germann, R; Schneider, G; Berger, A; Mischinger, HJ; Rehak, P Hyperthermia as an adjuvant to radiation- and/or chemotherapy in far advanced recurrences of the head and neck region.
Strahlenther Onkol. 1987; 163(7):449-452
Web of Science PubMed Google Scholar



Jakse, R; Scherlacher, A; Lehnert, M; Haas, J Chemotherapy of recurrent squamous cell carcinomas in the ENT area with cisplatin/adriamycin (DDP/ADM) and methotrexate/5-fluorouracil (MTX/5-Flu): a retrospective comparison of 2 protocols
HNO. 1986; 34(6):235-240
Web of Science PubMed



Scherlacher, A; Jakse, R; Lehnert, M Therapy of recurrent squamous cell cancers in the ENT area with the sequential methotrexate (MTX)/5-fluorouracil (5-Fu) protocol
Laryngol Rhinol Otol (Stuttg). 1985; 64(2):58-61 Doi: 10.1055/s-2007-1008087
Web of Science PubMed FullText FullText_MUG



Lehnert, M; Jakse, R; Seewann, HL Drug therapy in advanced squamous cell carcinoma of the ORL region
Onkologie. 1984; 7(5):297-299 Doi: 10.1159/000215464
Web of Science PubMed FullText FullText_MUG



Jakse, R; Lehnert, M; Scherlacher, A Palliative chemotherapy of recurring squamous cell carcinomas of the ENT field with the combination cis-diamminodichloroplatinum (II)/adriamycin
Laryngol Rhinol Otol (Stuttg). 1982; 61(9):524-528 Doi: 10.1055/s-2007-1008622
Web of Science PubMed FullText FullText_MUG


© Med Uni Graz Impressum